INTS Latest Press Releases

-- November 5, 2026 --

Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update PRNewswire 7:45 AM

-- October 30, 2026 --

Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026 PRNewswire 8:00 AM

-- October 23, 2026 --

Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting PRNewswire 8:00 AM

-- September 8, 2026 --

Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference PRNewswire 8:00 AM

-- August 11, 2026 --

NeOnc Approaches a Major Biotech Inflection Point as tomorrow's Brain-Cancer Data is set to Collide with a Tight Float Globe Newswire 11:00 AM

Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update PRNewswire 7:31 AM

-- August 4, 2026 --

Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 PRNewswire 8:00 AM

-- July 15, 2026 --

Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study) PRNewswire 7:45 AM

-- July 1, 2026 --

Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6 PRNewswire 8:00 AM

Market Data Delayed 15 Minutes